ATLANTA, GA--(Marketwire - October 26, 2010) - King & Spalding announced today that William R. Spalding, a former executive vice president of CVS Caremark, has rejoined the firm as a partner in the corporate practice. He will focus primarily on developing new clients and expanding existing business in the healthcare services, branded pharmaceuticals and healthcare information technology sectors, and providing advice in governance, internal investigations and disclosure matters to corporate boards of directors and audit committees. Spalding also will be active in King & Spalding's industry initiatives on healthcare and the life sciences (pharmaceuticals, biotechnology and medical devices).
"We are pleased to welcome our former colleague and friend Bill Spalding back to the firm," said Raymond E. Baltz, Jr., head of King & Spalding's corporate practice. "Bill's extensive experience as both a top practitioner within the legal profession and a senior executive in the healthcare/pharmaceutical industry strengthens our ability to provide clients with superior service and essential insight into their business and legal needs."
Spalding is returning to King & Spalding after serving as executive vice president, strategic initiatives at Caremark, Rx, Inc., and executive vice president, strategy and managed care at CVS Caremark Corporation. At Caremark, he led the CVS Caremark merger team in 2007, which included defending against a hostile proxy fight and tender offer by a competitor. Following the merger, Spalding was a member of the CVS Caremark executive management committee and had responsibility for corporate strategy, mergers and acquisitions, the pharmaceutical services and Medicare Part D businesses of the combined companies, as well as the CVS managed care operations. In April 2008, he co-founded The CrawfordSpalding Group, a professional advisory and management services firm based in Nashville, Tenn.
Spalding is chairman of the board of directors of MedVantx, Inc., and a board member of PharMEDium Healthcare Corporation and SecureWorks, Inc.
At King & Spalding, Spalding previously represented clients in merger and acquisition transactions in the healthcare, financial services and healthcare information technology sectors, and represented corporate boards of directors and audit committees in governance, Securities and Exchange Commission compliance and reporting matters. He also led a number of high profile independent investigations on behalf of the audit committees of large public companies. Spalding served as a practice group leader and was a member of King & Spalding's governing body, its policy committee. He is a graduate of Dartmouth College and received a J.D. degree, summa cum laude, from Washington & Lee University School of Law.
"I am delighted to be returning to King & Spalding," said Spalding. "I know from personal experience that King & Spalding is a great firm with talented lawyers and a wonderful place to practice law. I look forward to working with my new colleagues in the corporate, healthcare and pharmaceutical practices."
About King & Spalding
Celebrating 125 years of service, King & Spalding is an international law firm with more than 800 lawyers in Abu Dhabi, Atlanta, Austin, Charlotte, Dubai, Frankfurt, Geneva, Houston, London, New York, Paris, Riyadh (affiliated office), San Francisco, Silicon Valley, Singapore and Washington, D.C. The firm represents half of the Fortune 100 and, according to a Corporate Counsel survey in August 2009, ranks fifth in its total number of representations of those companies. For additional information, visit www.kslaw.com.
Contact Information:
Contact:
Matt Hyams
212.827.4057
mhyams@kslaw.com